That's right GD, everyone that is cancer free and was in the Multikine arm knows it. How many have kept it a secret?
The method of administering Multikine necessitated that the trial be open label.
open-label study A clinical study in which the patients/subjects and investigators know which product each patient/subject is receiving, which is the opposite of a blinded study.
(Oh, here he goes with his quotes and url links again!)(I'll spare the links.)
? Multikine is administered in supra-physiological doses locally (near or close) to the tumor and the adjacent lymph nodes. 5days/wk for 3wks prior to surgery.
By a hypodermic needle
SOC only comparative arm - was not given a placebo shot 5days/wk for 3wks prior to surgery.
Participants and investigators know who received Multikine.
That is how it is open label study.
Like most people, am working diligently to de-risk this investment.
In one of my web fishing expeditions, found the telltale signs of others fishing for trial participants. Didn't get any bites...